Shopping Cart 0
Cart Subtotal
USD 0

Astellas Pharma Inc (4503) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company's product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, infectious diseases, cancer, diseases and disorders of central nervous system (CNS), and metabolic diseases, immunodeficiency diseases, and transplantation. The company is investigating enfortumab vedotin in Phase 2 and Phase 3 clinical trials for the treatment of urothelial cancer; zolbetuximab in Phase 3 clinical trials for the treatment of gastric cancer and gastroesophageal junction cancer; roxadustat in Phase 3 clinical studies for the treatment of patients with anemia associated with chronic kidney disease (CKD) in patients on dialysis and non-dialysis; fezolinetant in Phase 2a clinical trials for the treatment of menopause-related vasomotor symptoms (MR-VMS) such as hot flashes and night sweats; and gilteritinib for the treatment of for acute myeloid leukemia (AML). It operates in the Americas; Europe; and Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.

Astellas Pharma Inc (4503)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Astellas Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Astellas Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Astellas Pharma Inc, Medical Equipment, Deal Details 11

Venture Financing 11

Euroscreen Raises USD17.8 Million in Series B Financing Round 11

Ganymed Pharmaceuticals Secures USD60.74 Million in Venture Funding 13

Partnerships 14

Astellas US and Academy of Oncology Nurse & Patient Navigators (AONN+) Enter into Partnership 14

Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 15

Qiagen Enters into Co-Development Agreement with Astellas Pharma 16

Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 17

Equity Offering 18

Advanced Cell to Raise USD30 Million in Private Placement of Shares 18

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For USD 35 Million 19

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For USD 1 Million 20

Asset Transactions 21

Grunenthal to Acquire Qutenza from Astellas Pharma Europe 21

Acquisition 22

Astellas Pharma Acquires Ganymed Pharma 22

Astellas Pharma Inc-Key Competitors 24

Astellas Pharma Inc-Key Employees 25

Astellas Pharma Inc-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Joint Venture 34

Recent Developments 35

Financial Announcements 35

Oct 31, 2018: Astellas announce financial results of for the first six months of FY2018 35

Apr 26, 2018: Astellas Reports Financial Results for FY2017 39

Jan 31, 2018: Astellas Reports Financial Results for the First Nine Months of FY2017 41

Oct 31, 2017: Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year Outlook 43

Jul 28, 2017: Astellas Reports First Quarter FY2017 Financial Results 45

Apr 27, 2017: Astellas Reports Full Year FY2016 Financial Results 47

Jan 31, 2017: Astellas Reports the First Nine Months Financial Results of FY2016 49

Corporate Communications 50

Nov 12, 2018: Astellas names Eloiza Domingo-Snyder to Head of Diversity and Inclusion 50

Sep 18, 2018: Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US 51

Aug 23, 2018: Astellas announces promotion of Rodrigo Fernandez to Vice President, Latin America 52

Jun 08, 2018: Astellas names Nahrin Marino to Vice President, Head of Ethics & Compliance Americas 53

May 15, 2018: Astellas Names Bernhardt Zeiher As New Chief Medical Officer 54

Mar 28, 2018: Astellas Appoints Tatjana Dragovic, J.D. Head of Ethics & Compliance 55

Mar 15, 2018: Astellas Names Percival Barretto-Ko President, Americas Operations 56

Mar 13, 2018: Astellas Announces Key Leadership Changes in Legal, Human Resources 57

Jan 31, 2018: Astellas Appoints Kenji Yasukawa as President and CEO 58

Jan 08, 2018: Astellas Announces Leadership Changes in Canada and U.S. 59

Dec 13, 2017: Astellas Appoints Anthony Fiordaliso to Vice President, Americas Finance 60

Dec 04, 2017: Astellas Appoints Joao Carlos de Britto as General Manager of Astellas Farma Brasil 61

Dec 01, 2017: Astellas Announces Personnel Change 62

Nov 01, 2017: Astellas Announces Leadership Changes in U.S. Health Systems Commercial Organization 63

Oct 31, 2017: Astellas Appoints Nate Crisel to Vice President, Real World Informatics & Analytics 64

Oct 30, 2017: Astellas Appoints Gary Thal, M.D., to Vice President, Specialty, Medical Affairs, Americas 65

Aug 24, 2017: Astellas Announces Personnel Changes and Organizational Changes 66

Jun 26, 2017: Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations 67

May 11, 2017: Astellas Names Shontelle Dodson Senior Vice President and Head of Medical Affairs Americas 68

Apr 28, 2017: Astellas Announces Key Leadership Promotions in Development Organization 69

Apr 27, 2017: Astellas Pharma Announces Changes of Representative Directors and Directors 70

Feb 08, 2017: Astellas Announces Changes in Management Structure and Global Function 72

Feb 08, 2017: Astellas Announces Personnel Changes and Organizational Changes 73

Legal and Regulatory 75

May 31, 2017: Astellas Announces New Global Website Launch 75

Government and Public Interest 76

May 31, 2018: Astellas Oncology C3 Prize Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World 76

Jul 05, 2017: Astellas Named to FTSE4Good Sustainability Index for the Sixth Consecutive Year 77

Other Significant Developments 78

Oct 23, 2018: Astellas and BANDAI NAMCO entertainment to jointly develop Smartphone Exercise Support App 78

Oct 09, 2018: Astellas details progress and commitment to patients and the community in the company's americas 2017 corporate social responsibility report card 79

Feb 05, 2018: Astellas Announces Changes in Management Structure, Global Function, and Top Management Committees 80

Feb 05, 2018: Astellas Announces Organizational Changes 81

Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma 82

Appendix 85

Methodology 85

About GlobalData 85

Contact Us 85

Disclaimer 85


List Of Figure

List of Figures

Astellas Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Astellas Pharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Astellas Pharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Astellas Pharma Inc, Medical Equipment, Key Facts, 2018 2

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Astellas Pharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Astellas Pharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Astellas Pharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Astellas Pharma Inc, Deals By Market, 2012 to YTD 2018 9

Astellas Pharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Euroscreen Raises USD17.8 Million in Series B Financing Round 11

Ganymed Pharmaceuticals Secures USD60.74 Million in Venture Funding 13

Astellas US and Academy of Oncology Nurse & Patient Navigators (AONN+) Enter into Partnership 14

Medivation and NanoString Technologies Enters into Partnership With Astellas Pharma 15

Qiagen Enters into Co-Development Agreement with Astellas Pharma 16

Astellas Pharma Enters Into Co-Marketing Agreement With Nippon Kayaku For A670 17

Advanced Cell to Raise USD30 Million in Private Placement of Shares 18

Advanced Cell Technology Files Registration Statement For Public Offering Of Securities For USD 35 Million 19

Advanced Cell Technology Completes First Tranche Of Private Placement Of Shares For USD 1 Million 20

Grunenthal to Acquire Qutenza from Astellas Pharma Europe 21

Astellas Pharma Acquires Ganymed Pharma 22

Astellas Pharma Inc, Key Competitors 24

Astellas Pharma Inc, Key Employees 25

Astellas Pharma Inc, Other Locations 28

Astellas Pharma Inc, Subsidiaries 28

Astellas Pharma Inc, Joint Venture 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Astellas Pharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.